Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$484M |
| 3 |
Amazon
AMZN
|
$482M |
| 4 |
Netflix
NFLX
|
$345M |
| 5 |
Pfizer
PFE
|
$314M |
Top Sells
| 1 |
Apple
AAPL
|
$900M |
| 2 |
Microsoft
MSFT
|
$393M |
| 3 |
UnitedHealth
UNH
|
$388M |
| 4 |
Merck
MRK
|
$272M |
| 5 |
Bank of America
BAC
|
$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLDO
3001
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $179K | ﹤0.01% |
+29,180
| New | +$179K |
|
3002
MainStreet Bancshares
MNSB
$171M
| $178K | ﹤0.01% |
10,592
| – | – |
|
|
GFN
3003
DELISTED
General Finance Corporation
GFN
| $178K | ﹤0.01% |
28,531
-33
| -0.1% | -$206 |
|
3004
Permian Resources
PR
$9.75B
| $177K | ﹤0.01% |
672,487
-1,821,402
| -73% | -$479K |
|
3005
Avalo Therapeutics
AVTX
$153M
| $176K | ﹤0.01% |
25
+5
| +25% | +$35.2K |
|
3006
Marker Therapeutics
MRKR
$11.6M
| $176K | ﹤0.01% |
9,255
+2,264
| +32% | +$43.1K |
|
|
GNC
3007
DELISTED
GNC Holdings, Inc.
GNC
| $176K | ﹤0.01% |
377,415
+71,432
| +23% | +$33.3K |
|
3008
Commercial Vehicle Group
CVGI
$68.1M
| $175K | ﹤0.01% |
115,984
-46,585
| -29% | -$70.3K |
|
3009
Alpha Metallurgical Resources
AMR
$1.91B
| $174K | ﹤0.01% |
74,346
-128
| -0.2% | -$300 |
|
3010
Esquire Financial Holdings
ESQ
$828M
| $174K | ﹤0.01% |
11,563
| – | – |
|
|
VNET
3011
VNET Group
VNET
$2.13B
| $172K | ﹤0.01% |
12,400
-1,500
| -11% | -$20.8K |
|
3012
Ponce Financial Group
PDLB
$339M
| $168K | ﹤0.01% |
22,794
| – | – |
|
|
ACOR
3013
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $167K | ﹤0.01% |
1,491
+79
| +6% | +$8.85K |
|
3014
Liquidia Corp
LQDA
$2.48B
| $165K | ﹤0.01% |
34,945
+23
| +0.1% | +$109 |
|
3015
EyePoint Pharmaceuticals
EYPT
$966M
| $164K | ﹤0.01% |
16,068
+131
| +0.8% | +$1.34K |
|
3016
Cibus
CBUS
$67.3M
| $161K | ﹤0.01% |
967
+283
| +41% | +$47.1K |
|
3017
Solid Biosciences
SLDB
$428M
| $159K | ﹤0.01% |
4,429
-42
| -0.9% | -$1.51K |
|
3018
Ring Energy
REI
$207M
| $158K | ﹤0.01% |
240,252
+3,831
| +2% | +$2.52K |
|
3019
MPLX
MPLX
$51.5B
| $156K | ﹤0.01% |
13,423
-12,439
| -48% | -$145K |
|
|
LEAF
3020
DELISTED
Leaf Group Ltd.
LEAF
| $154K | ﹤0.01% |
114,495
+615
| +0.5% | +$827 |
|
|
TCS
3021
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $153K | ﹤0.01% |
4,330
-1,132
| -21% | -$40K |
|
|
SRT
3022
DELISTED
Startek Inc.
SRT
| $152K | ﹤0.01% |
40,619
-167
| -0.4% | -$625 |
|
3023
Aldeyra Therapeutics
ALDX
$334M
| $151K | ﹤0.01% |
61,063
-78,319
| -56% | -$194K |
|
3024
Coastal Financial
CCB
$1.66B
| $151K | ﹤0.01% |
14,377
| – | – |
|
3025
Duluth Holdings
DLTH
$142M
| $151K | ﹤0.01% |
37,632
-35
| -0.1% | -$140 |
|